151 related articles for article (PubMed ID: 38183101)
41. Human papillomavirus infection: Epidemiology, biology, host interactions, cancer development, prevention, and therapeutics.
Wolf J; Kist LF; Pereira SB; Quessada MA; Petek H; Pille A; Maccari JG; Mutlaq MP; Nasi LA
Rev Med Virol; 2024 May; 34(3):e2537. PubMed ID: 38666757
[TBL] [Abstract][Full Text] [Related]
42. Impact of HPV vaccination with Gardasil® in Switzerland.
Jacot-Guillarmod M; Pasquier J; Greub G; Bongiovanni M; Achtari C; Sahli R
BMC Infect Dis; 2017 Dec; 17(1):790. PubMed ID: 29273004
[TBL] [Abstract][Full Text] [Related]
43. Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study.
Oakeshott P; Aghaizu A; Reid F; Howell-Jones R; Hay PE; Sadiq ST; Lacey CJ; Beddows S; Soldan K
BMJ; 2012 Jun; 344():e4168. PubMed ID: 22730542
[TBL] [Abstract][Full Text] [Related]
44. Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.
Bergman H; Buckley BS; Villanueva G; Petkovic J; Garritty C; Lutje V; Riveros-Balta AX; Low N; Henschke N
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31755549
[TBL] [Abstract][Full Text] [Related]
45. Prevalence of genital human papillomavirus DNA in a sample of senior school-aged women in the Australian Capital Territory.
O'Keefe EJ; Gardner A; Currie MJ; Garland S; Tabrizi S; Bowden FJ
Sex Health; 2006 May; 3(2):91-4. PubMed ID: 16800394
[TBL] [Abstract][Full Text] [Related]
46. The prevalence and genotype distribution of human papillomavirus among women in Guangxi, southern China.
Wei L; Ma L; Qin L; Huang Z
Infect Agent Cancer; 2022 Apr; 17(1):19. PubMed ID: 35449004
[TBL] [Abstract][Full Text] [Related]
47. Distribution of genital human papillomavirus genotypes in benign clinical manifestations among men from Northern Spain.
Arroyo LS; Basaras M; Arrese E; Hernáez S; Esteban V; Cisterna R
BMC Public Health; 2016 Jan; 16():81. PubMed ID: 26817692
[TBL] [Abstract][Full Text] [Related]
48. Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study.
Chow EPF; Machalek DA; Tabrizi SN; Danielewski JA; Fehler G; Bradshaw CS; Garland SM; Chen MY; Fairley CK
Lancet Infect Dis; 2017 Jan; 17(1):68-77. PubMed ID: 27282422
[TBL] [Abstract][Full Text] [Related]
49. Human papillomavirus prevalence and genotype distribution in Vietnamese male patients between 2016 and 2020.
Hoai BN; Cao TN; Luong Thi LA; Nguyen MN; Duong HQ; Than VT
J Med Virol; 2022 Jun; 94(6):2892-2896. PubMed ID: 34859458
[TBL] [Abstract][Full Text] [Related]
50. Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.
Park IU; Introcaso C; Dunne EF
Clin Infect Dis; 2015 Dec; 61 Suppl 8():S849-55. PubMed ID: 26602622
[TBL] [Abstract][Full Text] [Related]
51. Prevalence of human papilloma virus in Oman: Genotypes 82 and 68 are dominating.
Al-Lawati Z; Khamis FA; Al-Hamdani A; Al-Kalbani M; Ramadhan FA; Al-Rawahi TR; Al-Kobaisi MF
Int J Infect Dis; 2020 Apr; 93():22-27. PubMed ID: 31935539
[TBL] [Abstract][Full Text] [Related]
52. Distribution of genital wart human papillomavirus genotypes in China: a multi-center study.
Chang L; Ci P; Shi J; Zhai K; Feng X; Colombara D; Wang W; Qiao Y; Chen W; Wu Y
J Med Virol; 2013 Oct; 85(10):1765-74. PubMed ID: 23861100
[TBL] [Abstract][Full Text] [Related]
53. High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N'Djamena, Chad.
Mboumba Bouassa RS; Nodjikouambaye ZA; Sadjoli D; Adawaye C; Péré H; Veyer D; Matta M; Robin L; Tonen-Wolyec S; Moussa AM; Koyalta D; Belec L
PLoS One; 2019; 14(6):e0217486. PubMed ID: 31158254
[TBL] [Abstract][Full Text] [Related]
54. The impact of the COVID-19 pandemic on the prevalence and genotype distribution of HPV infection in Beijing, China.
Yi J; Li X; Zhang R; Kong L; Wang Z; Yu Q; Zhang H; Chen B; Li S; Xu Y; Chen Y
J Med Virol; 2023 Oct; 95(10):e29155. PubMed ID: 37815056
[TBL] [Abstract][Full Text] [Related]
55. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
Ndizeye Z; Vanden Broeck D; Lebelo RL; Bogers J; Benoy I; Van Geertruyden JP
PLoS One; 2019; 14(6):e0209303. PubMed ID: 31237894
[TBL] [Abstract][Full Text] [Related]
56. Oncogenic human papillomavirus infection and genotypes characterization among sexually active women in Tenkodogo at Burkina Faso, West Africa.
Ouedraogo RA; Zohoncon TM; Guigma SP; Angèle Traore IM; Ouattara AK; Ouedraogo M; Djigma FW; Obiri-Yeboah D; Ouedraogo C; Simpore J
Papillomavirus Res; 2018 Dec; 6():22-26. PubMed ID: 30244072
[TBL] [Abstract][Full Text] [Related]
57. HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory.
Jiang L; Tian X; Peng D; Zhang L; Xie F; Bi C; Wang R; Wang J; Qi D
PLoS One; 2019; 14(1):e0210311. PubMed ID: 30653566
[TBL] [Abstract][Full Text] [Related]
58. Prevalence of high-risk HPV and its genotypes-Implications in the choice of prophylactic HPV vaccine.
Suresh A; Suresh P; Biswas R; Rajanbabu A; Sreedhar S; Biswas L
J Med Virol; 2021 Aug; 93(8):5188-5192. PubMed ID: 33851736
[TBL] [Abstract][Full Text] [Related]
59. Possible Synergistic Interactions Among Multiple HPV Genotypes in Women Suffering from Genital Neoplasia.
Hajia M; Sohrabi A
Asian Pac J Cancer Prev; 2018 Mar; 19(3):785-789. PubMed ID: 29582635
[TBL] [Abstract][Full Text] [Related]
60. Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine.
Ährlund-Richter A; Cheng L; Hu YOO; Svensson M; Pennhag AAL; Ursu RG; Haeggblom L; Grün N; Ramqvist T; Engstrand L; Dalianis T; Du J
Front Cell Infect Microbiol; 2019; 9():59. PubMed ID: 30949454
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
